Recommendation 10

To defeat covid-19, and tackle future pandemics, a wider range of countries need the ability to produce vaccines. The production of AstraZeneca by India’s Serum Institute offers a good model for technology transfer to build this capacity. Many national leaders have backed the call for a temporary waiver on intellectual property for covid-19 vaccines. We recommend that the Government pursues a wide range of means to bring about greater manufacturing capacity in lower-income countries, including through expanded technology transfer schemes. In its response to this report, the Government should set out the steps it is taking to transfer vaccine technology to low- and middle-income countries, and its goals in terms of increasing global vaccine production.